 | Up a level |
Jump to: Journal Article
Number of items: 1.
Journal Article
Thomas, M., Schuler, M., Potzner, M., Szczudlo, T., Sutradhar, S., Yovine, A. and Wolf, J. (2015). Experience from the ASCEND-1 trial: Ceritinib in patients (Pts) with ALK-rearranged (ALK plus ) Non-Small Cell Lung Cancer (NSCLC) and brain metastases. Oncol. Res. Treat., 38. S. 270 - 271. BASEL: KARGER. ISSN 2296-5262